Abstract
Malignant ovarian neoplasms are uncommon in the pediatric and adolescent population.
Imaging and tumor markers help to guide the preoperative risk/benefit analysis for
planned surgical management, which is the mainstay of therapy. An interdisciplinary
approach should be taken in the management of this vulnerable population from diagnosis
through post-treatment surveillance. In this review, the initial evaluation, risk
stratification, and management of various types of malignant ovarian masses will be
addressed, with a special focus on how to optimize an interdisciplinary approach to
ovarian masses.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Pediatric and Adolescent GynecologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- (Edited by)Gynecologic benign and malignant cysts/masses/tumors.in: Emans SJ Laufer MR DiVasta AD Emans, Laufer, & Goldstein's Pediatric and Adolescent Gynecology. 7th ed. Wolters Kluwer, Philadelphia2020: 558-569 (Edited by)
- Factors associated with management of pediatric ovarian neoplasms.Pediatrics. 2019; 1: 144
- Ovarian masses in children and adolescents an analysis of 521 clinical cases.J Pediatr Adolesc Gynecol. 2014; 3: 27
- Effect of surgical specialty on management of adnexal masses in children and adolescents: an 8-year single-center review.J Pediatr Adolesc Gynecol. 2020; 1: 33
- A preoperative scoring system for adnexal mass in children and adolescents to preserve their future fertility.J Pediatr Adolesc Gynecol. 2019; 1: 32
- Treatment and ovarian preservation in children with ovarian tumors.J Pediatr Surg. 2015; 12: 50
- Variability in surgical management of benign ovarian neoplasms in children.J Pediatr Surg. 2017; 6: 52
- Impact of surgeon specialty on ovarian-conserving surgery in young females with an adnexal mass.J Adolesc Health. 2006; 3: 39
- A retrospective review of the effect of surgeon specialty on the management of 190 benign and malignant pediatric and adolescent adnexal masses.J Pediatr Adolesc Gynecol. 2011; 5: 24
- Borderline ovarian tumor in the pediatric and adolescent population: a case series and literature review.J Pediatr Adolesc Gynecol. 2018; 1: 31
- The multidisciplinary approach to ovarian tumours in children and adolescents.Eur J Obstet Gynecol Reprod Biol. 2019; 243: 243
- Counseling adolescents and the challenges for genetic counselors.J Genet Couns. 2012; 4: 21
- Experience with genetic counseling: the adolescent perspective.J Genet Couns. 2016; 3: 25
- Imaging of pediatric ovarian neoplasms.Pediatr Radiol. 2011; 9: 41
- (Edited by)Radiologic imaging.in: Emans SJ Laufer MR DiVasta AD Emans, Laufer, & Goldstein's Pediatric and Adolescent Gynecology. 7th ed. Wolters Kluwer, Philadelphia2020: 575-608 (Edited by)
- Pediatric ovarian malignancy presenting as ovarian torsion: incidence and relevance.J Pediatr Surg. 2010; 1: 45
- Clinically oriented three-step strategy for assessment of adnexal pathology.Ultrasound Obstet Gynecol. 2012; 5: 40
- Simple descriptors and simple rules of the International Ovarian Tumor Analysis (IOTA) Group: a prospective study of combined use for the description of adnexal masses.Eur J Obstet Gynecol Reprod Biol. 2015; 195: 195
- Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group.Am J Obstet Gynecol. 2016; 4: 214
- O-RADS US risk stratification and management system: a consensus guideline from the ACR ovarian-adnexal reporting and data system committee.Radiology. 2020; 1: 294
- Can we preoperatively risk stratify ovarian masses for malignancy?.J Pedatr Surg. 2010; 1: 45
- Preoperative risk stratification of adnexal masses: can we predict the optimal surgical management?.J Pediatr Adolesc Gynecol. 2014; 3: 27
- Preoperative risk stratification of children with ovarian tumors.J Pediatr Surg. 2016; 51: 9
- The role of preoperative imaging and tumor markers in predicting malignant ovarian masses in children.Pediatr Surg Int. 2020; 3: 36
- An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations.Gynecol Oncol. 2017; 1: 146
- Risk of second primary tumors after childhood and adolescent ovarian malignancies: a SEER analysis (1973–2011).J Pediatr Adolesc Gynecol. 2015; 6: 28
- Benign, borderline, and malignant pediatric adnexal masses: a ten-year review.J Pediatr Adolesc Gynecol. 2021; 34https://doi.org/10.1016/j.jpag.2021.01.002
- ACOG Committee Opinion No. 747: Gynecologic issues in children and adolescent cancer patients and survivors.Obstet Gynecol. 2018; 2: 132
- Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative.Cancer. 2016; 2: 122
Article info
Publication history
Published online: October 27, 2021
Accepted:
October 18,
2021
Received in revised form:
October 10,
2021
Received:
August 19,
2021
Footnotes
Disclosures/Conflicts of Interest: Drs. Khaja, Weil, Weldon, Frazier, and Shim do not have any conflicts of interest to disclose. Dr. Laufer is the director of the Boston Center for Endometriosis, which receives funding from the J. Willard and Alice S. Marriott Foundation. Dr. Laufer is also on the International Advisory Board of AbbVie pharmaceuticals, an advisor for NextGen Jane, and an author for UpToDate.
Identification
Copyright
© 2021 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights reserved.
